Company attributes
Other attributes
Scorpion Therapeutics is a company that is operating to widen the reach of precision medicine to more patients with cancer, including treatment-resistant cancers or cancers that can't be treated today. The company is working to change the status quo, drawing on the expertise of its team and driving to accelerate its impact on patients.
The company's team comprises of renowned experts in cancer biology, targeted oncology, and drug development. It pioneers in cataloging and understanding the cellular mechanisms and genomic events that bring about cancer; identifying and characterizing the molecular subtypes of disease; designing pharmacological interventions to stop these disease processes and speeding up the clinical translation of new insights into transformative targeted therapies for patients.
The company is integrating modern and advanced technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments.
